Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Francesca Guerrini"'
Autor:
Barbara Izzo, Fabrizio Quarantelli, Ciro Del Prete, Alessandra Potenza, Santa Errichiello, Roberta Visconti, Alessandra Galdiero, Angelo Zanniti, Ida Pisano, Mariangela Capone, Giuliano Pennacchio, Manuel De Marco, Maurizio Capuozzo, Claudia Venturi, Emanuela Ottaviani, Clara Bono, Francesca Guerrini, Michael Bates, Grace Macaulay, Tran Tran, Jessica Dosanjh, Krupa Shridar, Enrico Gottardi, Emilia Giugliano, Alice Danzero, Paola Berchialla, Carmen Fava
Publikováno v:
HemaSphere, Vol 7, p e10742d3 (2023)
Externí odkaz:
https://doaj.org/article/0247ba51337c48a199204cb392351964
Autor:
Serena Salehzadeh, Francesca Guerrini, Umberto Pizzano, Susanna Grassi, Elena Ciabatti, Lorenzo Iovino, Gabriele Buda, Francesco Caracciolo, Edoardo Benedetti, Enrico Orciuolo, Matteo Pelosini, Giovanni Consani, Giovanni Carulli, Maria Rita Metelli, Francesca Martini, Francesco Mazziotta, Elisa Mazzantini, Pietro Rossi, Rita Tavarozzi, Federica Ricci, Mario Petrini, Sara Galimberti
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-15 (2019)
Abstract Background In addition to morphological and cytogenetic features, acute myeloid leukemias are characterized by mutations that can be used for target-therapy; also the minimal/measurable residual disease (MRD) could be an important prognostic
Externí odkaz:
https://doaj.org/article/b3ed2a20c6eb42cc835f2b6750f72efe
Publikováno v:
Diagnostics, Vol 12, Iss 6, p 1305 (2022)
Digital droplet PCR (ddPCR) is a recent version of quantitative PCR (QT-PCR), useful for measuring gene expression, doing clonality assays and detecting hot spot mutations. In respect of QT-PCR, ddPCR is more sensitive, does not need any reference cu
Externí odkaz:
https://doaj.org/article/89f0e9f656734d4b9278467d28977ebc
Autor:
Sara Galimberti, Mario Petrini, Claudia Baratè, Federica Ricci, Serena Balducci, Susanna Grassi, Francesca Guerrini, Elena Ciabatti, Sandra Mechelli, Antonello Di Paolo, Chiara Baldini, Laura Baglietto, Lisa Macera, Pietro Giorgio Spezia, Fabrizio Maggi
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
SARS-CoV-2 is the viral agent responsible for the pandemic that in the first months of 2020 caused about 400,000 deaths. Among compounds proposed to fight the SARS-CoV-2-related disease (COVID-19), tyrosine kinase inhibitors (TKIs), already effective
Externí odkaz:
https://doaj.org/article/008940af48964fb69bb44c865433b1e1
Autor:
Federica Ricci, Serena Balducci, Francesca Guerrini, Susanna Grassi, Elena Ciabatti, Claudia Baratè, Maria Immacolata Ferreri, Cecilia Giuliani, Angelo Valetto, Mario Petrini, Sara Galimberti
Publikováno v:
Clinical Hematology International, Vol 2, Iss 3 (2020)
Externí odkaz:
https://doaj.org/article/4e73241241fb4fafa6a98e133a4f50a2
Autor:
Sara Galimberti, Elisa Genuardi, Francesco Mazziotta, Lorenzo Iovino, Fortunato Morabito, Susanna Grassi, Elena Ciabatti, Francesca Guerrini, Mario Petrini
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Minimal residual disease (MRD) in non-Hodgkin's lymphomas (NHLs) still represents matter of interest and debate: indeed, the new available treatments offer higher rates of complete responses and MRD negativity than in the past, with a positive impact
Externí odkaz:
https://doaj.org/article/8e69ab0163fe43b099563a91e74a4962
Autor:
Susanna Grassi, Sara Palumbo, Veronica Mariotti, Diego Liberati, Francesca Guerrini, Elena Ciabatti, Serena Salehzadeh, Claudia Baratè, Serena Balducci, Federica Ricci, Gabriele Buda, Lorenzo Iovino, Francesco Mazziotta, Francesco Ghio, Giacomo Ercolano, Antonello Di Paolo, Antonella Cecchettini, Chiara Baldini, Letizia Mattii, Silvia Pellegrini, Mario Petrini, Sara Galimberti
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Notwithstanding the introduction of Tyrosine Kinase Inhibitors (TKIs) revolutionized the outcome of Chronic Myeloid Leukemia (CML), one third of patients still suspends treatment for failure response. Recent research demonstrated that several BCR/ABL
Externí odkaz:
https://doaj.org/article/28ae6790330a483ea33f3ea5cbfc0329
Autor:
Sara Galimberti, Susanna Grassi, Claudia Baratè, Francesca Guerrini, Elena Ciabatti, Francesca Perutelli, Federica Ricci, Giada Del Genio, Marina Montali, Serena Barachini, Cecilia Giuliani, Maria Immacolata Ferreri, Angelo Valetto, Elisabetta Abruzzese, Chiara Ippolito, Alessandra Iurlo, Monica Bocchia, Anna Sicuranza, Bruno Martino, Lorenzo Iovino, Gabriele Buda, Serena Salehzadeh, Mario Petrini, Antonello Di Paolo, Letizia Mattii
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
The Polycomb gene BMI1 expression exerts a negative predictive impact on several hematological malignancies, such as acute and chronic myeloid leukemia (CML), myelofibrosis, and follicular lymphoma. As already demonstrated in CML, BMI1 is responsible
Externí odkaz:
https://doaj.org/article/2bc841b0944a485f95437b0b3a5c2f75
Autor:
Daniela Drandi, Elisa Genuardi, Irene Dogliotti, Martina Ferrante, Cristina Jiménez, Francesca Guerrini, Mariella Lo Schirico, Barbara Mantoan, Vittorio Muccio, Giuseppe Lia, Gian Maria Zaccaria, Paola Omedè, Roberto Passera, Lorella Orsucci, Giulia Benevolo, Federica Cavallo, Sara Galimberti, Ramón García Sanz, Mario Boccadoro, Marco Ladetto, Simone Ferrero
Publikováno v:
Haematologica, Vol 103, Iss 6 (2018)
We here describe a novel method for MYD88L265P mutation detection and minimal residual disease monitoring in Waldenström macroglobulinemia, by droplet digital polymerase chain reaction, in bone marrow and peripheral blood cells, as well as in circul
Externí odkaz:
https://doaj.org/article/4fc3f4450e914b82b4d4fdeb149692b9
Autor:
Gabriele Buda, Francesca Guerrini, Sara Galimberti, Enrico Orciuolo, Simone Pacini, Elisa Mazzantini, Mario Petrini
Publikováno v:
Hematology Reports, Vol 9, Iss 4 (2017)
Human positive regulatory domain I binding factor 1 (PRDI-BF1 or BLIMP-1) is a transcription factor that acts as a master regulator and has crucial roles in the control of differentiation and in maintaining survival of plasma cells (PC). The PRDM1 ge
Externí odkaz:
https://doaj.org/article/597cf498665e41f0af4a00516a2edd85